{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "10951721", "DateCompleted": {"Year": "2000", "Month": "09", "Day": "05"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "30"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0820-3946", "JournalIssue": {"Volume": "163", "Issue": "3", "PubDate": {"Year": "2000", "Month": "Aug", "Day": "08"}}, "Title": "CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne", "ISOAbbreviation": "CMAJ"}, "ArticleTitle": "St. John's wort and schizophrenia.", "Pagination": {"StartPage": "262", "EndPage": "263", "MedlinePgn": "262-3"}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Lal", "ForeName": "S", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Iskandar", "ForeName": "H", "Initials": "H"}], "PublicationTypeList": ["Case Reports", "Letter"]}, "MedlineJournalInfo": {"Country": "Canada", "MedlineTA": "CMAJ", "NlmUniqueID": "9711805", "ISSNLinking": "0820-3946"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antipsychotic Agents"}, {"RegistryNumber": "12794-10-4", "NameOfSubstance": "Benzodiazepines"}, {"RegistryNumber": "3G0285N20N", "NameOfSubstance": "Pirenzepine"}, {"RegistryNumber": "L6UH7ZF8HC", "NameOfSubstance": "Risperidone"}, {"RegistryNumber": "N7U69T4SZR", "NameOfSubstance": "Olanzapine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Acute Disease"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antipsychotic Agents"}, {"QualifierName": [], "DescriptorName": "Benzodiazepines"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Hypericum"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Olanzapine"}, {"QualifierName": ["analogs & derivatives", "therapeutic use"], "DescriptorName": "Pirenzepine"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Recurrence"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Risperidone"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Schizophrenia"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Deltito J, Beyer D. The scientific quasi-scientific and popular literature on the use of St. John's wort in the treatment of depression J Affect Disord 1998;51(3):345-51.", "ArticleIdList": ["10333988"]}, {"Citation": "Bennett DA, Phun L, Polk JF, Voglino SA, Zlotnik V, Raffa LB. Neuropharmacology of St. John's wort (Hypericum). Ann Pharmacother 1998;32:1201-8.", "ArticleIdList": ["9825087"]}, {"Citation": "Neary JT, Bu YR. Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytes. Brain Res 1999;816:358-63.", "ArticleIdList": ["9878826"]}, {"Citation": "Chavez ML, Chavez PI. St. John's wort. Hosp Pharm 1997;32:1621-32."}, {"Citation": "Nierenberg AA, Burt T, Mathews J, Weiss AP. Mania associated with St. John's wort. Biol Psychiatry 1999;46:1707-8.", "ArticleIdList": ["10624554"]}, {"Citation": "Schneck C. St. John's wort and hypomania. J Clin Psychiatry 1998;59:689.", "ArticleIdList": ["9921706"]}, {"Citation": "Kalinowsky LB, Hippius H. Pharmacological, convulsive and other somatic treatments in psychiatry. New York: Grune & Stratton; 1969."}]}], "History": [{"Year": "2000", "Month": "8", "Day": "22", "Hour": "11", "Minute": "0"}, {"Year": "2000", "Month": "9", "Day": "9", "Hour": "11", "Minute": "1"}, {"Year": "2000", "Month": "8", "Day": "22", "Hour": "11", "Minute": "0"}, {"Year": "2000", "Month": "8", "Day": "8"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10951721", "PMC80286"]}}], "PubmedBookArticle": []}